Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TRN-213 by Tris Pharma for Muscle Spasticity: Likelihood of Approval
TRN-213 is under clinical development by Tris Pharma and currently in Phase I for Muscle Spasticity. According to GlobalData, Phase...
Cebranopadol by Tris Pharma for Pain: Likelihood of Approval
Cebranopadol is under clinical development by Tris Pharma and currently in Phase II for Pain. According to GlobalData, Phase II...
Cebranopadol by Tris Pharma for Opium (Opioid) Addiction: Likelihood of Approval
Cebranopadol is under clinical development by Tris Pharma and currently in Phase I for Opium (Opioid) Addiction. According to GlobalData,...
Cebranopadol by Tris Pharma for Chronic Low Back Pain (CLBP): Likelihood of Approval
Cebranopadol is under clinical development by Tris Pharma and currently in Phase II for Chronic Low Back Pain (CLBP). According...